The Governors of the University of Calgary

🇨🇦Canada

Country: 🇨🇦Canada

Ownership: Private

Established: 1966-04-29

Employees: 1K

Market Cap: -

Website: http://www.ucalgary.ca

Clinical Trials

ENCOMPASS: Expansion Study C

Not Applicable

Completed

Conditions: Hypertension
Ischemic Heart Disease
Diabetes Mellitus, Type 2
Asthma
Congestive Heart Failure
Chronic Kidney Diseases
Chronic Obstructive Pulmonary Disease

Interventions: Behavioral: Community Health Navigator Program

First Posted Date: 2021-03-10

Last Posted Date: 2024-05-23

Lead Sponsor: University of Calgary

Target Recruit Count: 61

Registration Number: NCT04791267

Locations: 🇨🇦
WestView Primary Care Network, Edmonton, Alberta, Canada

ENCOMPASS: Expansion Study A, RCT

Not Applicable

Completed

Conditions: Chronic Kidney Diseases
Ischemic Heart Disease
Hypertension
Congestive Heart Failure
Diabetes Mellitus, Type 2
Chronic Obstructive Pulmonary Disease
Asthma

Interventions: Behavioral: Community Health Navigator Program

First Posted Date: 2021-03-10

Last Posted Date: 2024-05-23

Lead Sponsor: University of Calgary

Target Recruit Count: 96

Registration Number: NCT04790604

Locations: 🇨🇦
Edmonton Oliver Primary Care Network, Edmonton, Alberta, Canada

EXCEL: Technology and Exercise Adherence

Not Applicable

Conditions: Cancer

Interventions: Device: ZoeInsights Application
Behavioral: EXCEL Exercise Class

First Posted Date: 2021-03-10

Last Posted Date: 2022-04-07

Lead Sponsor: University of Calgary

Target Recruit Count: 140

Registration Number: NCT04790578

Locations: 🇨🇦
University of Calgary, Calgary, Alberta, Canada

The Canadian Maraviroc Randomized Controlled Trial To Augment Rehabilitation Outcomes After Stroke

Phase 2

Recruiting

Conditions: Stroke

Interventions: Drug: Maraviroc
Behavioral: Exercise Program
Other: Placebo
Device: Activity Sensor
Behavioral: Motor Learning

First Posted Date: 2021-03-09

Last Posted Date: 2024-07-09

Lead Sponsor: University of Calgary

Target Recruit Count: 120

Registration Number: NCT04789616

Locations: 🇨🇦
Dalhousie University, Halifax, Nova Scotia, Canada
🇨🇦
Toronto Rehabilitation Institute - University Health Network, Toronto, Ontario, Canada
🇨🇦
Parkwood Institute, London, Ontario, Canada

and more 3 locations

HoloStream Study - Video Capture Device Usage

Not Applicable

Conditions: Fistula
Nephrostomy; Complications
Central Venous Catheter Thrombosis

Interventions: Other: VSI streamer and Microsoft Hololens 2 classed as a Class III device by Health Canada.

First Posted Date: 2021-03-01

Last Posted Date: 2021-03-01

Lead Sponsor: University of Calgary

Target Recruit Count: 100

Registration Number: NCT04774588

Remote Exercise Maintenance With Health Coaching for Cancer Survivors

Not Applicable

Completed

Conditions: Cancer Survivors

Interventions: Behavioral: Health Coaching
Behavioral: Online delivered Exercise Classes

First Posted Date: 2021-02-12

Last Posted Date: 2021-02-12

Lead Sponsor: University of Calgary

Target Recruit Count: 39

Registration Number: NCT04751305

Locations: 🇨🇦
Faculty of Kinesiology University of Calgary, Calgary, Alberta, Canada
🇨🇦
Health and Wellness Lab, University of Calgary, Calgary, Alberta, Canada

Treatment of Nosocomial COVID-19

Phase 4

Terminated

Conditions: Covid19
SARS-CoV2 Infection
Nosocomial Infection

Interventions: Drug: Anti-SARS-CoV-2 mAb

First Posted Date: 2021-02-10

Last Posted Date: 2023-04-19

Lead Sponsor: University of Calgary

Target Recruit Count: 46

Registration Number: NCT04748588

Locations: 🇨🇦
University of Calgary, Calgary, Alberta, Canada
🇨🇦
University of Alberta, Edmonton, Alberta, Canada
🇨🇦
Hôpital Montfort, Ottawa, Ontario, Canada

and more 1 locations

Vernakalant Versus Amiodarone for Post-operative Atrial Fibrillation in Cardiac Surgery Patients

Phase 3

Not yet recruiting

Conditions: Atrial Fibrillation
Post-cardiac Surgery

Interventions: Drug: Amiodarone
Drug: Vernakalant

First Posted Date: 2021-02-10

Last Posted Date: 2024-05-22

Lead Sponsor: University of Calgary

Target Recruit Count: 50

Registration Number: NCT04748991

Identification and Treatment of Hypoxemic Respiratory Failure and ARDS With Protection, Paralysis, and Proning Pathway

Not Applicable

Active, not recruiting

Conditions: Hypoxemic Respiratory Failure
ARDS, Human
Acute Respiratory Distress Syndrome

Interventions: Other: TheraPPP

First Posted Date: 2021-02-08

Last Posted Date: 2024-06-25

Lead Sponsor: University of Calgary

Target Recruit Count: 19916

Registration Number: NCT04744298

Locations: 🇨🇦
Peter Lougheed Centre (PLC), Calgary, Alberta, Canada
🇨🇦
Misericordia Community Hospital, Edmonton, Alberta, Canada
🇨🇦
Mazankowski Alberta Heart Institute, Edmonton, Alberta, Canada

and more 14 locations

The Effect of Platelet Rich Plasma on Partial Thickness Rotator Cuff Tears: A Randomized Controlled Trial

Phase 4

Completed

Conditions: Rotator Cuff Injuries

Interventions: Drug: Corticosteroid (CS)
Biological: Platelet Rich Plasma (PRP)

First Posted Date: 2021-02-08

Last Posted Date: 2021-02-08

Lead Sponsor: University of Calgary

Target Recruit Count: 104

Registration Number: NCT04743986

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy